Skip to main content
. 2024 Mar 11;15:2026. doi: 10.1038/s41467-024-46174-2

Table 1.

A summary of the datasets utilized in the study, with percentages of BE-positive and negative cases

Dataset Study Patients (slide pairs) BE-positive BE-negative
Discovery development set (train, validation) DELTA 912 348 (38.2%) 564 (61.8%)
Discovery test set DELTA 229 87 (38.0%) 142 (62.0%)
External test set (holdout) BEST2 725 329 (45.4%) 396 (54.6%)
Total 1866 764 (40.9%) 1102 (59.1%)